Clinical Trials
19 trialsNCT04527991 2026-06-02
TROPiCS-04
Gilead Sciences
Phase 3 Completed
NCT07419295 2026-05-29
TroFuse-031
Merck Sharp & Dohme LLC
Phase 3 Recruiting
NCT03390504 2026-05-11
THOR
Janssen Research & Development, LLC
Phase 3 Active not recruiting
NCT03474107 2026-01-09
A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
Astellas Pharma Inc
Phase 3 Completed
NCT01095003 2022-04-28
Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer
Pierre Fabre Medicament
Phase 3 Completed
NCT02256436 2021-09-20
MK-3475-045
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT01091168 2019-09-16
Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer
Pierre Fabre Medicament
Phase 3 Completed
NCT02302807 2019-08-01
A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]
Hoffmann-La Roche
Phase 3 Completed
NCT01953003 2019-05-02
Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
Pierre Fabre Medicament
Phase 3 Completed
NCT02347332 2019-03-05
Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer
Pierre Fabre Medicament
Phase 3 Completed
NCT02845050 2018-02-13
JaNEO
Ligartis GmbH
Phase 1/2 Withdrawn
NCT00362830 2016-09-19
A Study of the Alternative Administration of Ixabepilone and Vinflunine
Bristol-Myers Squibb
Phase 1 Completed
NCT00388557 2016-09-19
Effect of Ketoconazole on the Pharmacokinetics of Vinflunine
Bristol-Myers Squibb
Phase 1 Completed
NCT01599013 2015-12-08
JASINT1
Pierre Fabre Medicament
Phase 2 Completed
NCT00389155 2015-12-07
First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
Bristol-Myers Squibb
Phase 2/3 Completed
NCT00534807 2015-09-01
A Study of the Interaction of Rifampin and Vinflunine in Subjects With Advanced Cancer
Bristol-Myers Squibb
Phase 1 Withdrawn
NCT00101608 2010-03-02
Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
Bristol-Myers Squibb
Phase 2 Completed
NCT00359476 2010-03-02
A Study of Vinflunine in Patients With Gastric Cancer
Bristol-Myers Squibb
Phase 2/3 Terminated
NCT00315237 2010-01-07
Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract
Bristol-Myers Squibb
Phase 3 Completed